Citicoline
Best-in-class: Citicoline
A premium choline source that boosts both acetylcholine (focus/memory) and dopamine receptor density (motivation), and supports brain cell-membrane repair.
Citicoline quick facts
| Suggested dose | 250–500 mg daily. |
| How often | Daily |
| Who it's for | Focus, motivation, memory and brain-membrane support. |
The best human trial base of any choline source, covering attention and memory in both older adults with cognitive decline and healthy young people. The dual mechanism makes it the better choice for sustained cognitive support, while Alpha-GPC edges it for acute focus and power output. Well tolerated. More expensive per gram of choline delivered, which is what you are paying for the cytidine.
How Citicoline actually works
CDP-choline delivers two active molecules rather than one. The choline half feeds acetylcholine synthesis; the cytidine half converts to uridine, which combines with choline and DHA to build phosphatidylcholine — the structural material of neuronal membranes and synapses. So it supports both the neurotransmitter and the hardware, which is a genuinely different profile from a pure choline salt.
Where to get Citicoline
Find Citicoline on iHerb →The evidence for Citicoline
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show improved attention, memory and cognitive performance; used clinically for cognitive impairment and stroke recovery.
- Supports membrane phospholipid synthesis and dopamine signaling.
📊 Correlative data
- Choline availability supports acetylcholine-driven cognition.
🧪 Theoretical / extrapolated benefits
- Neuroprotective/membrane-repair roles are well-grounded; one of the better-evidenced nootropics.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Citicoline actually does
Citicoline is cytidine-5'-diphosphocholine, and its name is its whole pharmacological argument. Every cell builds phosphatidylcholine down the Kennedy pathway in three steps: choline kinase makes phosphocholine; CTP:phosphocholine cytidylyltransferase makes CDP-choline; and cholinephosphotransferase hands the choline head group to diacylglycerol to finish the phospholipid. The middle enzyme is the rate-limiting one, and it is regulated in an unusual way — it is amphitropic, switching between an inactive soluble form and an active membrane-bound form according to the lipid composition of the membrane it lands on Cornell 2015. It is a sensor, not a valve. It speeds up when the membrane is short of phosphatidylcholine, and swallowing more choline does not persuade it otherwise.
So the pitch is elegant: citicoline is the product of the regulated step, therefore it enters downstream of the regulation. That would be a real advantage over every other choline product on the shelf, and it is why this molecule is priced the way it is.
It is also not what happens. Oral citicoline is hydrolyzed before and during absorption into cytidine and choline, which are taken up separately and reassembled inside cells. The intact dinucleotide is not what crosses the gut wall, which means the dose re-enters the pathway upstream of the very enzyme it was sold as bypassing, and the review literature is blunt that the mechanism of citicoline's pharmacological action has no adequate description Grieb 2014. This single fact reorganizes the entire product, and no label carries it.
What that leaves is a two-substrate delivery vehicle, and the second substrate is the interesting one. Choline is one half; the other half is cytidine, and in humans circulating cytidine is scarce — it is deaminated, and the pyrimidine that actually rides in human plasma is uridine. So in a person, a citicoline dose reads as choline plus a pyrimidine feed into the CTP pool, which is a different sentence from the one on the box and is the reason this page and the uridine page are about the same pathway Grieb 2014. The dopamine-receptor-density claim, meanwhile, is exactly the kind of statement the same review declines to consider established.
Cell, rodent, human — and where it stops
The enzymology is solid and it is about membranes, not cognition Cornell 2015. Everything after this point is a clinical question.
The two adequately powered human trials are the ones nobody quotes. ICTUS randomized 2,298 patients with acute ischemic stroke to citicoline 1,000 mg intravenously every 12 hours for 3 days followed by 500 mg orally twice daily for 6 weeks, or placebo. The global recovery odds ratio was 1.03, p = 0.364, and the trial was stopped for futility Davalos 2012. COBRIT randomized 1,213 patients with traumatic brain injury across 8 US trauma centers to 2,000 mg daily for 90 days; favorable outcome occurred in 35.4% on citicoline against 35.6% on placebo, with no treatment effect at 90 or 180 days Zafonte 2012. Between them, 3,511 patients and two flat lines.
The trial the marketing rests on is much smaller and its win was on the second tier. One hundred healthy adults aged 50 to 85 took 500 mg/day for 12 weeks; the significant improvements were in secondary outcomes — episodic memory and a composite memory score Nakazaki 2021. When the European Food Safety Authority assessed the memory claim in 2024, that was essentially the dataset: one randomized trial showing benefit at 500 mg/day for 12 weeks, no effect at 1 g/day, and no effect in dementia populations EFSA NDA Panel 2024.
The obstacle here is a shape, not a gap. The dose-response is non-monotonic in the wrong direction — positive at 500 mg, nothing at 1,000 mg, nothing at the 2,000 mg used in the big trauma trial EFSA NDA Panel 2024 Zafonte 2012. And the one positive trial enrolled people aged 50 to 85, whose episodic memory had somewhere to move. A 32-year-old taking 250 mg for focus sits below the only dose that has ever worked, in a decade of life that has never been tested, on an endpoint the trial reached second.
Citicoline — which form, and does it matter
Work out the choline content and the shelf reorders itself. Citicoline free acid has a molecular weight near 488 and carries one choline moiety of 104, so it is about 21% choline by mass. Alpha-GPC is 257 with the same 104, so about 41%. Choline bitartrate is 253 and also about 41%. In choline terms, 500 mg of citicoline delivers roughly 105 mg of choline — less than 250 mg of alpha-GPC does. If choline delivery were the point of buying this, it would be the wrong purchase.
Which means the case for citicoline is the cytidine half or it is nothing. That is a defensible position and it is worth stating plainly: you are not buying an efficient choline salt, you are buying a pyrimidine and a choline together, on the argument that membrane synthesis needs both Cornell 2015 Grieb 2014. Nobody has tested that argument against its own components, which is the experiment named further down this page.
Alpha-GPC is the comparator most buyers are actually choosing between, and the two have different liabilities. Alpha-GPC has a meta-analysis behind it in adult-onset cognitive dysfunction, largely alongside donepezil in clinical populations Sagaro 2023; it also delivers twice the choline per milligram, and choline is the substrate gut bacteria turn into trimethylamine Tang 2013. Citicoline's lower choline fraction is a genuine advantage on that axis and a disadvantage on the cholinergic one. Neither label frames it as a trade.
Match the trial material if you are going to run the experiment. The positive healthy-ageing result used a specific commercial citicoline at 500 mg once daily for 12 weeks Nakazaki 2021, and the 2022 pharmacological review catalogs how much of the clinical literature is tied to particular preparations Secades 2022. Two 250 mg capsules of an unspecified powder is a guess dressed as a dose.
What would have to be true, and how you would know it was not
1. Run the dose the trial ran, or expect the trial's silence. 500 mg once daily for 12 weeks, with a delayed word-list recall and a sustained-attention task scored at day 0 and day 84. Predict a small improvement in delayed recall if you are over 50 and none if you are under 40, because 50 to 85 is the only age band with a positive result Nakazaki 2021 EFSA NDA Panel 2024.
2. The prediction that cuts against the product, twice over. First: predict that going up to 1,000 mg makes it worse rather than better, because 1 g/day is where the effect disappears in the assessed dataset EFSA NDA Panel 2024. Second: predict that TMAO rises. Choline is a trimethylamine substrate for gut bacteria and TMAO is an orderable test that tracked major adverse cardiovascular events with a hazard ratio of 2.54 in 4,007 patients Tang 2013. A choline product that does nothing for your memory and moves your TMAO has cost you twice.
3. Blood pressure, and a caffeine rule. Citicoline can lower blood pressure slightly, so a home cuff is a cheap engagement check. And hold caffeine flat across the whole 12 weeks: it is the loudest thing in the same lane, and a citicoline trial run while you also change your coffee is not a trial.
What will fool you: initiation. This product is sold on motivation, and starting a hard task is exactly the observation most sensitive to having just bought something for it. Score a task with a right answer, not a feeling.
What nobody has tested yet
The decisive experiment is a three-arm trial and it has never been run. Citicoline 500 mg against an equimolar dose of choline alone against choline plus uridine, with the same cognitive battery. That single design would establish whether the molecule is worth more than the sum of its two fragments — which is the entire premise of the product, given that it is taken apart before absorption Grieb 2014.
Nobody has measured plasma choline and uridine alongside the cognitive endpoint in the same people. The positive trial reported memory scores Nakazaki 2021; without concurrent plasma measurements there is no exposure-response relationship for citicoline in cognition at all, which is why the 500-versus-1,000 mg inversion EFSA NDA Panel 2024 cannot currently be explained.
Nobody has tested it in healthy adults under 50. That is the population buying it. A 12-week randomized trial at 500 mg in 30- to 45-year-olds with an objective attention battery is unglamorous, cheap by the standards of the two stroke and trauma trials Davalos 2012 Zafonte 2012, and absent.
And nobody has checked whether it is a net TMAO producer at label doses. Six weeks at 500 mg with a fasting TMAO at each end would settle whether the lower choline fraction of this molecule actually buys the metabolic advantage that its chemistry implies Tang 2013.
Citicoline — its own safety story, not its category's
The tolerability record is genuinely good, and it is worth saying so. Citicoline has been given at 2,000 mg/day for 90 days to 1,213 people with traumatic brain injury Zafonte 2012 and at 1,000 mg intravenously twice daily to over a thousand stroke patients Davalos 2012. Those are large, monitored, dosed safety datasets, which is more than almost anything else in this category can put on the table. The usual reports are insomnia, headache and gastrointestinal upset.
The risk that is specific to this molecule is metabolic, not neurological. Roughly a fifth of the mass is choline, gut bacteria convert a share of any choline load to trimethylamine, and hepatic flavin-containing monooxygenase 3 oxidizes that to TMAO, which was associated with major adverse cardiovascular events at a hazard ratio of 2.54 across 4,007 patients undergoing coronary angiography Tang 2013. The experiment that makes this concrete for a supplement used alpha-GPC rather than citicoline: in hyperlipidemic Apoe-knockout mice it promoted atherosclerosis, through TMAO and an altered gut microbiota Wang 2021. Citicoline carries about half the choline per milligram that alpha-GPC does, so the honest framing is that it is the smaller version of the same load, not that it has none.
Do not stack choline sources without a reason. Alpha-GPC, choline bitartrate, phosphatidylcholine, a high-choline multivitamin and citicoline are all the same cholinergic axis. Cholinergic overshoot presents as headache, nausea, sweating and vivid dreams rather than as sharpness, and those symptoms are a signal to come down.
Who should not take it: anyone with low resting blood pressure who is already lightheaded on standing; anyone taking a cholinesterase inhibitor, because that is the same axis from the other end and the combination has not been studied at supplement doses; and anyone taking it as a substitute for investigating a genuine cognitive change, which is a clinical assessment rather than a purchase.
Sources read for this page
- Cornell RB, Ridgway ND. CTP:phosphocholine cytidylyltransferase: Function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis. Progress in Lipid Research 2015 · PMID 26165797
- Grieb P. Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs 2014 · PMID 24504829
- Davalos A, Alvarez-Sabin J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012 · PMID 22691567
- Zafonte RD, Bagiella E, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 2012 · PMID 23168823
- Nakazaki E, Mah E, et al. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Nutrition 2021 · PMID 33978188
- EFSA NDA Panel. 'Citicoline' and support of the memory function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2024 · PMID 38966137
- Secades JJ, Gareri P. Citicoline: pharmacological and clinical review, 2022 update. Revista de Neurologia 2022 · PMID 36544369
- Sagaro GG, et al. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease 2023 · PMID 36683513
- Tang WH, Wang Z, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine 2013 · PMID 23614584
- Wang Z, et al. The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis. International Journal of Molecular Sciences 2021 · PMID 34948275
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Whether you start the thing you have been avoiding. Its dopaminergic arm shows up as initiation rather than raw sharpness, so the countable version is how many times this week you sat down to the hard task without an hour of small easy ones first.
- How long before it means anything: Two to four weeks at 250 to 500 mg. It carries more human data than most of this shelf and the attention findings sit inside that window, so a month here is a fair test rather than an impatient one.
- What will fool you: Comparing it against caffeine. It is quieter, which reads as weaker on day one, and if you drink coffee alongside it the coffee is louder and takes the credit. Hold your caffeine flat across the trial instead of changing two things and attributing the result to the expensive one.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Citicoline — safety & side effects
- Well tolerated — insomnia, headache and GI upset are the usual reports.
- Cholinergic. Same interaction class as alpha-GPC; do not stack multiple high-dose choline sources without reason.
- May lower blood pressure. Well studied at 250–2,000 mg with a good safety record, which is more than most things in this category can claim.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Citicoline in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Citicoline
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Citicoline — frequently asked questions
What is Citicoline?
A premium choline source that boosts both acetylcholine (focus/memory) and dopamine receptor density (motivation), and supports brain cell-membrane repair.
What is the suggested dose of Citicoline?
250–500 mg daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Citicoline dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Citicoline?
Coach Cam sources Citicoline from vetted, top-rated brands on iHerb — use the buy link on this page.
Citicoline inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Citicoline is used for
Citicoline appears under 1 goal in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Citicoline is the cholinergic arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.